Gooreind Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Gooreind Pharma
Largest movements
- Receivables within one year -€68,043
down €68,043 (-29.3%), from €232,290 to €164,247
of which Trade receivables: -€55,912
- Tangible fixed assets -€47,376
down €47,376 (-14.8%), from €320,352 to €272,975
of which Other tangible fixed assets: -€38,872
- Cash +€19,798
up €19,798 (+24.6%), from €80,537 to €100,334
mainly Receivables within one year (+€68,043) and Net result for the year (+€59,344)
- Stocks and contracts +€9,646
up €9,646 (+4.5%), from €214,589 to €224,234
- Other debts -€45,245
down €45,245 (-42.9%), from €105,395 to €60,150
- Debts after one year -€39,981
down €39,981 (-17.7%), from €225,357 to €185,376
- Gross operating margin +€26,478
up €26,478 (+5.7%), from €460,528 to €487,006
- Staff costs +€26,126
up €26,126 (+8.3%), from €315,205 to €341,331
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €879,574 | €791,241 | -€88,332 | -10.0% |
| Fixed assets | 21/28 | €328,153 | €280,482 | -€47,671 | -14.5% |
| Intangible fixed assets | 21 | €2,801 | €2,506 | -€295 | -10.5% |
| Tangible fixed assets | 22/27 | €320,352 | €272,975 | -€47,376 | -14.8% |
| Land and buildings | 22 | €47,342 | €40,142 | -€7,200 | -15.2% |
| Plant, machinery and equipment | 23 | €3,253 | €8,470 | +€5,218 | +160.4% |
| Furniture and vehicles | 24 | €9,813 | €3,291 | -€6,522 | -66.5% |
| Other tangible fixed assets | 26 | €259,944 | €221,072 | -€38,872 | -15.0% |
| Financial fixed assets | 28 | €5,000 | €5,000 | = | 0.0% |
| Current assets | 29/58 | €551,421 | €510,760 | -€40,661 | -7.4% |
| Stocks and contracts in progress | 3 | €214,589 | €224,234 | +€9,646 | +4.5% |
| Stocks | 30/36 | €214,589 | €224,234 | +€9,646 | +4.5% |
| Amounts receivable within one year | 40/41 | €232,290 | €164,247 | -€68,043 | -29.3% |
| Trade receivables | 40 | €215,529 | €159,617 | -€55,912 | -25.9% |
| Other amounts receivable | 41 | €16,761 | €4,631 | -€12,130 | -72.4% |
| Cash at bank and in hand | 54/58 | €80,537 | €100,334 | +€19,798 | +24.6% |
| Deferred charges and accrued income | 490/1 | €24,005 | €21,944 | -€2,061 | -8.6% |
| Total equity and liabilities | 10/49 | €879,574 | €791,241 | -€88,332 | -10.0% |
| Equity | 10/15 | €390,682 | €390,026 | -€656 | -0.2% |
| Contributions | 10/11 | €19,200 | €19,200 | = | 0.0% |
| Reserves | 13 | €371,482 | €370,826 | -€656 | -0.2% |
| Tax-exempt reserves | 132 | €18,750 | €18,750 | = | 0.0% |
| Distributable reserves | 133 | €352,732 | €352,076 | -€656 | -0.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €488,892 | €401,216 | -€87,676 | -17.9% |
| Amounts payable after more than one year | 17 | €225,357 | €185,376 | -€39,981 | -17.7% |
| Financial debts | 170/4 | €225,357 | €185,376 | -€39,981 | -17.7% |
| Amounts payable within one year | 42/48 | €263,535 | €215,839 | -€47,696 | -18.1% |
| Current portion of amounts payable after more than one year | 42 | €39,549 | €39,981 | +€431 | +1.1% |
| Trade debts | 44 | €79,488 | €73,031 | -€6,458 | -8.1% |
| Suppliers | 440/4 | €79,488 | €73,031 | -€6,458 | -8.1% |
| Taxes, remuneration and social security | 45 | €39,102 | €42,678 | +€3,576 | +9.1% |
| Taxes | 450/3 | €758 | €2,039 | +€1,281 | +169.1% |
| Remuneration and social security | 454/9 | €38,344 | €40,639 | +€2,295 | +6.0% |
| Other amounts payable | 47/48 | €105,395 | €60,150 | -€45,245 | -42.9% |
| Remuneration, social security and pensions | 62 | €315,205 | €341,331 | +€26,126 | +8.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €57,286 | €54,279 | -€3,007 | -5.2% |
| Other operating charges | 640/8 | €260 | €394 | +€133 | +51.3% |
| Gross operating margin | 9900 | €460,528 | €487,006 | +€26,478 | +5.7% |
| Operating profit (loss) | 9901 | €87,777 | €91,002 | +€3,225 | +3.7% |
| Financial charges | 65/66B | €8,417 | €8,524 | +€107 | +1.3% |
| Recurring financial charges | 65 | €8,417 | €8,524 | +€107 | +1.3% |
| Profit (loss) for the period before taxes | 9903 | €79,360 | €82,478 | +€3,118 | +3.9% |
| Income taxes | 67/77 | €22,235 | €23,134 | +€899 | +4.0% |
| Profit (loss) for the period | 9904 | €57,125 | €59,344 | +€2,219 | +3.9% |
| Profit (loss) for the period to be appropriated | 9905 | €57,125 | €59,344 | +€2,219 | +3.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.